Oxaliplatin 100 Mg Injection

Oxaliplatin 100 Mg Injection Specification

Indication
Colorectal cancer, metastatic colorectal carcinoma

Dosage Form
Injection

Salt Composition
Oxaliplatin 100 mg

Feature
Ready to use, sterile, cytotoxic

Ingredients
Oxaliplatin, water for injection, stabilizers

Application
Intravenous use only

Ph Level
As per company norms

Physical Color/Texture
Clear, colorless to slightly yellow solution

Fermentation Smell
Normal Smell

Storage Instructions
Dry place

Shelf Life
upto 24 Months

Precautions
Administer under supervision of a qualified healthcare professional

Use in Pediatrics
Safety and efficacy not established in children

Compatibility
Compatible with 5% dextrose injection

Administration Route
Intravenous (IV) infusion

Prescription Status
Prescription only

Packaging Type
Single-use glass vial

Cytotoxic Handling
Handle with cytotoxic precautions (personal protective equipment required)

Strength/Volume
100 mg/20 ml vial

Contraindication
Hypersensitivity to platinum-containing compounds

Disposal
Dispose as per hazardous waste protocol

Reconstitution
Ready-to-use, no dilution required unless specified

Oxaliplatin 100 Mg Injection Trade Information

Minimum Order Quantity
10 Units

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Units Per Month

Delivery Time
7-10 Seconds

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

Main Domestic Market
All India

About Oxaliplatin 100 Mg Injection

Unlock the crowning solution in oncology with Oxaliplatin 100 Mg Injection (Dacotin-100), a premier cytotoxic agent specifically crafted for metastatic colorectal cancer treatment. Delivered in a splendiferous ready-to-use 100 mg/20 ml sterile single-use glass vial, this prescription-only injection is administered via intravenous infusion and boasts compatibility with 5% dextrose. Utilise this offer for your clinical or hospital needs-Get It Now and experience hassle-free preparation, precise dosing, and up to 24 months shelf life. Handle with cytotoxic precautions and dispose of safely as per protocol. Exported and wholesaled from India, meeting leading industry benchmarks.

Select Oxaliplatin 100 Mg Injection for Specific Clinical Applications

Oxaliplatin 100 Mg Injection stands as a trusted choice for clinicians treating advanced colorectal cancer and metastatic colorectal carcinoma. Its streamlined formulation is ideal for plant application in hospital settings, supporting ready-to-use protocols and minimising preparation errors. The primary competitive advantage includes proven efficacy, premier compatibility with standard dextrose solutions, and its splendiferous convenience-no dilution required unless otherwise specified-making it a crowning addition to oncology therapeutics.

Main Domestic & Export Markets: Delivery and Secure Shipping Assured

Dr. Reddys Laboratories Ltd. ensures a robust domestic presence in India, offering prompt delivery and quotations on demand. With an established reputation as both exporter and wholesaler, Oxaliplatin 100 Mg Injection reaches premier markets globally through FOB ports and secure shipping practices. Main export destinations include leading regions in Asia, Africa, and the Middle East, further solidifying its market presence and reliability for international clients seeking splendiferous service and compliance.

Specification

Brand	Dacotin-100
Directions for Use	Lyophilized For Intravenous Infusion, sterile Single Dose Vial
Form	Injection
Prescription/Non prescription	Prescription
Usage	Clinical,Hospital
Treatment	Colorectal Cancer
Manufacturer	Dr. Reddys Laboratories Ltd.
Composition	Oxaliplatin

FAQ's of Oxaliplatin 100 Mg Injection:

Q: How should Oxaliplatin 100 Mg Injection be administered for optimal safety?

A: Oxaliplatin 100 Mg Injection must be administered via intravenous infusion under the direct supervision of a qualified healthcare professional, adhering to cytotoxic handling precautions.

Q: What specific condition is Oxaliplatin 100 Mg Injection indicated for?

A: This injection is primarily indicated for the treatment of colorectal cancer, including metastatic colorectal carcinoma, as part of combination chemotherapy regimens.

Q: When is Oxaliplatin 100 Mg Injection contraindicated?

A: The injection is contraindicated in patients who exhibit hypersensitivity to platinum-containing compounds. It is also not established for use in children due to insufficient safety and efficacy data.

Q: Where can Oxaliplatin 100 Mg Injection be used?

A: It is designed for use in clinical and hospital environments where it can be overseen by specially trained medical professionals.

Q: What is the process for handling and disposing of Oxaliplatin 100 Mg Injection?

A: Due to its cytotoxic nature, it must be handled using personal protective equipment and disposed of according to hazardous waste protocols to ensure environmental and staff safety.